Research aarkstore enterprise musculoskeletal partnering agreements


Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Research aarkstore enterprise musculoskeletal partnering agreements

  1. 1. ResearchAarkstore Enterprise Musculoskeletal Partnering AgreementsThe Musculoskeletal Partnering Terms and Agreements report provides comprehensiveunderstanding and unprecedented access to the musculoskeletal partnering deals andagreements entered into by the worlds leading healthcare companiesThe report provides a detailed understanding and analysis of how and why companiesenter musculoskeletal partnering deals. The majority of deals are discovery ordevelopment stage whereby the licensee obtains a right or an option right to license thelicensors musculoskeletal technology. These deals tend to be multicomponent, startingwith collaborative R&D, and commercialization of outcomes.Understanding the flexibility of a prospective partner’s negotiated deals terms providescritical insight into the negotiation process in terms of what you can expect to achieveduring the negotiation of terms. Whilst many smaller companies will be seeking details ofthe payments clauses, the devil is in the detail in terms of how payments are triggered –contract documents provide this insight where press releases do not.This report contains over 1,500 links to online copies of actual musculoskeletal deals andcontract documents as submitted to the Securities Exchange Commission by companiesand their partners. Contract documents provide the answers to numerous questions abouta prospective partner’s flexibility on a wide range of important issues, many of whichwill have a significant impact on each party’s ability to derive value from the deal.The initial chapters of this report provide an orientation of musculoskeletal dealmakingand business activities. Chapter 1 provides an introduction to the report.Chapter 2 provides an overview of the trends in musculoskeletal dealmaking since 2007covering trends by year, deal type, stage of development, technology type and therapeuticindication. In addition the chapter includes an analysis of financial deal terms by stage atsigning covering headline value, upfront payment, milestone payments and royalty rates.Analysis includes median values and distribution of values for each stage ofdevelopment.Chapter 3 provides a review of the leading musculoskeletal deals since 2007. Deals arelisted by headline value, signed by bigpharma, most active bigpharma, and most active ofall biopharma companies. Where the deal has an agreement contract published at the SECa link provides online access to the contract.
  2. 2. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of musculoskeletal deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.For more information please visit link: Neel Aarkstore Enterprise Phone:08149852585 Partnering Terms & AgreementsCompanion Diagnostics Partnering Terms & AgreementsBioinformatics Partnering Terms & AgreementsPersonalized Medicine Partnering Terms and AgreementsPersonalized Medicine Partnering Terms and AgreementsDermatology Partnering Terms and AgreementsCardiovascular Partnering Terms and AgreementsObstretics Partnering 2007-2012Musculoskeletal Partnering AgreementsOncology Partnering Terms and AgreementsPediatrics Partnering Terms and AgreementsMetabolic Partnering Terms and AgreementsImmunology Partnering Terms and Agreements
  3. 3. Genitourinary Partnering Terms and AgreementsGastrointestinal Partnering Terms and AgreementsDental Partnering Terms and AgreementsCentral Nervous System Partnering Terms and AgreementsSexual Health Partnering Terms and AgreementsMucositis Partnering 2007-2012Oral Health Partnering 2007-2012AIDS Partnering 2007-2012Allergy Partnering 2007-2012Systemic Lupus Partnering 2007-2012Inflammatory Partnering 2007-2012Gynecology Partnering Terms and AgreementsRespiratory Partnering Terms and AgreementsBacterial Partnering Terms and AgreementsViral Partnering Terms and AgreementsAnthrax Partnering 2007-2012E.coli Partnering 2007-2012MRSA Partnering 2007-2012Sepsis Partnering 2007-2012Common Cold Partnering 2007-2012Hepatitis Partnering 2007-2012Herper simplex Partnering 2007-2012HIV Partnering 2007-2012Influenza Partnering 2007-2012RSV Partnering 2007-2012Parasitic Partnering 2007-2012Fungal Partnering 2007-2012Tropical Disease Partnering 2007-2012Dengue Fever Partnering 2007-2012Malaria Partnering 2007-2012Renal Failure Partnering 2007-2012Dialysis Partnering 2007-2012Genitourinary Symptoms Partnering 2007-2012
  4. 4. Chronic Kidney Disease Partnering 2007-2012Blood Substitute Partnering 2007-2012Anemia Partnering 2007-2012Hemophilia Partnering 2007-2012